Physicochemical characteristics and in vivo deposition of liposome-encapsulated tea catechins by topical and intratumor administrations

References

• Allen, TM, Hansen CB, Lopes de Menezes DE. 1995. Pharmaco- kinetics of long-circulating liposomes, Adv Drug Deliv Rev 16: 267–284.
   Google Scholar
• Blache D, Durand P, Prost M, Loreau N. 2002. (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo, Free Radic Biol Med 33:1670–1680.
   Google Scholar
• Buszello K, Harnisch S, Mu¨ ller RH, Mu¨ ller BW. 2000. The influence of alkali fatty acids on the properties and the stability of parenteral o/w emulsions modified with Solutol HS15w, Eur J Pharm Biopharm 49: 143–149.
   Google Scholar
• Cai Y, Anavy ND, Chow HS. 2002. Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats, Drug Metab Dispos 30:1246–1249.
   PubMed Web of Science ®Google Scholar
• Catterall F, King LJ, Clifford MN, Ioannides C. 2003. Bioavailability of dietary doses of 3H-labelled tea antioxidants (+)-catechin and (2)-epicatechin in rat, Xenobiotica 33:743–753.
   PubMed Web of Science ®Google Scholar
• Chen L, Lee MJ, Li H, Yang CS. 1997. Absorption, distribution, and elimination of tea polyphenols in rats, Drug Metab Dispos 25:1045–1050.
   PubMed Web of Science ®Google Scholar
• du Plessis J, Ramachandran C, Weiner N, Mu¨ ller DG. 1994. The influence of particle size of liposomes on the deposition of drug into skin, Int J Pharm 103:277–282.
   Web of Science ®Google Scholar
• Dvorakova K, Dorr RT, Valcic S, Timmermann B, Alberts DS. 1999. Pharmacokinetics of the green tea derivatives, EGCG, by the topical route of administration in mouse and human skin, Cancer Chemother Pharmacol 43: 331–335.
   PubMed Web of Science ®Google Scholar
• Fang JY, Lin HH, Hsu LR, Tsai YH. 1997. Characterization and stability of various liposome-encapsulated enoxacin formu- lations, Chem Pharm Bull 45:1504–1509.
   PubMed Web of Science ®Google Scholar
• Gabizon AA. 2002. Liposomal drug carrier systems in cancer chemotherapy: current status and future prospects, J Drug Target 10:535–538.
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. 1976. The carrier potential of liposomes in biology and medicine, New Engl J Med 295:704–710.
   PubMed Web of Science ®Google Scholar
• Harashima H, Tsuchihashi M, Iida S, Doi H, Kiwada H. 1999. Pharmacokinetic/pharmacodynamic modeling of antitumor agents encapsulated into liposomes, Adv Drug Deliv Rev 40:39–61.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Kumazawa S, Nanjo F, Hara Y, Nakayama T. 1999. Interaction of tea catechins with lipid bilayers investigated with liposome systems, Biosci Biotechnol Biochem 63:2252–2255.
   PubMed Web of Science ®Google Scholar
• Hazemoto N, Harada M, Suzuki S, Kaiho F, Haga M, Kato Y. 1993. Effect of phosphatidylcholine and cholesterol on pH-sensitive liposomes, Chem Pharm Bull 41:1003–1006.
   PubMed Web of Science ®Google Scholar
• Jain RK. 1989. Delivery of novel therapeutic agents in tumors: physiological barriers and strategies, J Natl Cancer Inst 81:570–576.
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Ahmad N, Mukhtar H. 2000. Green tea and skin, Arch Dermatol 136:989–994.
   PubMed Web of Science ®Google Scholar
• Kirjavainen M, Urtti A, Valjakka-Koskela R, Kiesvaara J, Mo¨ nkko¨ nen J. 1999. Liposome-skin interactions and their effects on the skin permeation of drugs, Eur J Pharm Sci 7: 279–286.
   Google Scholar
• Levin C, Maibach HI. 2002. Exploration of alternative and natural drugs in dermatology, Arch Dermatol 138: 207– 211.
   PubMed Web of Science ®Google Scholar
• Liu D, Mori A, Huang L. 1992. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes, Biochim Biophys Acta 1104:95–101.
   PubMed Web of Science ®Google Scholar
• Mizuguchi H, Nakanishi T, Nakanishi M, Nakagawa T, Nakagawa S, Mayumi T. 1996. Intratumor administration of fusogenic liposomes containing fragment A of diphtheria toxin suppresses tumor growth, Cancer Lett 100:63–69.
   PubMed Web of Science ®Google Scholar
• Nagayasu A, Uchiyama K, Kiwada H. 1999. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs, Adv Drug Deliv Rev 40:75–87.
   PubMed Web of Science ®Google Scholar
• Ogiso T, Niinaka N, Iwaki M, Tanino T. 1997. Mechanism for enhancement effect of lipid disperse system on percutaneous absorption. Part II, Int J Pharm 152:135–144.
   Web of Science ®Google Scholar
• Oku N. 1999. Anticancer therapy using glucuronate modified long- circulating liposomes, Adv Drug Deliv Rev 40:63–73.
   PubMed Web of Science ®Google Scholar
• Uchiyama K, Nagayasu A, Yamagiwa Y, Nishida T, Harashima H, Kiwada H. 1995. Effects of the size and fluidity of liposomes on their accumulation in tumors: a presumption of their interaction with tumor, Int J Pharm 121:195–203.
   Web of Science ®Google Scholar
• Valenta C, Janisch M. 2003. Permeation of cyproterone acetate through pig skin from different vehicles with phospholipids, Int J Pharm 258:133–139.
   PubMed Web of Science ®Google Scholar
• Verma DD, Verma S, Blume G, Fahr A. 2003. Particle size of liposomes influences dermal delivery of substances into skin, Int J Pharm 258:141–151.
   PubMed Web of Science ®Google Scholar
• Yamaguchi T. 1996. Lipid microspheres as drug carriers: a pharmaceutical point of view, Adv Drug Deliv Rev 20: 117–130. Yarosh D, Klein J, O’Connor A, Hawk J, Rafal E, Wolf P. 2001. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomized study, Lancet 357: 926–929.
   Google Scholar
• Yokomizo Y. 1996. Effect of phosphatidylcholine on the percuta- neous penetration of drugs through the dorsal skin of guinea pigs in vitro and analysis of the molecular mechanism using ATR- FTIR spectroscopy, J Control Release 42:249–262.
   Web of Science ®Google Scholar
• Zhu QY, Holt RR, Lazarus SA, Ensunsa JL, Hammerstone JF, Schmitz HH, Keen CL. 2002. Stability of the flavan-3-ols epicatechin and catechin and related dimeric procyanidins derived from cocoa, J Agric Food Chem 50:1700–1705.
   PubMed Web of Science ®Google Scholar